First gene therapy that targets leukemia approved in the US – WJBD Online
WJBD Online |
First gene therapy that targets leukemia approved in the US
WJBD Online Called "CAR-T cell therapy," it is the first gene therapy to enter the U.S. market. Novartis Pharmaceuticals priced the one-time infusion at $475,000. However, the company said it would waive costs for patients who didn't respond to the treatment … |
